AHA/BHA Hangi İçeriklerle Kullanılmaz? — cilt bariyeri bakımı | CIRÈLL

AHA/BHA: Which Ingredients Should Not Be Used With Them

Genuine AHA/BHA ingredient incompatibilities rest on documented pH conflicts and cumulative irritation mechanisms, warranting evidence-based distinction from the outdated or unsubstantiated combination myths that also circulate widely.

Key Findings

  • Tang and Yang's research on alpha-hydroxy acids' dual effects on skin provides foundational evidence relevant to understanding both AHA benefits and irritation-relevant cautions.[1]
  • Zasada and Budzisz's research on retinoids' influence on skin structure provides relevant context for the well-established retinoid-AHA/BHA combination caution.[2]
  • Al-Niaimi and Chiang's research on topical vitamin C mechanisms provides direct evidence for the pH-based formulation conflict relevant to combining vitamin C with AHA/BHA.[3]
  • Fluhr and Darlenski's research on skin surface pH mechanisms provides the foundational evidence base for understanding why pH-based conflicts represent genuine, rather than overstated, formulation concerns.[6]

Genuine Caution: Retinoids

Zasada and Budzisz's research on retinoids' influence on skin structure, combined with Leyden, Stein-Gold, and Weiss's research establishing retinoids as a therapeutic mainstay, together reinforce the well-established, genuine caution around combining retinoids with AHA/BHA on the same application — both independently increase transepidermal water loss and irritation potential, representing genuinely cumulative rather than merely additive risk.[2,8]

AHA/BHA: Which Ingredients Should Not Be Used With Them | CIRÈLL
AHA/BHA: Which Ingredients Should Not Be Used With Them

Genuine Caution: Low-pH Vitamin C

Al-Niaimi and Chiang's research on topical vitamin C mechanisms and clinical applications provides direct evidence for a genuine pH-based formulation conflict — L-ascorbic acid vitamin C's low-pH stability requirement creates measurable formulation tension with AHA/BHA products of differing pH, supported by Fluhr and Darlenski's broader research on skin surface pH mechanisms establishing why this pH-conflict concern is genuinely, rather than merely theoretically, relevant.[3,6]

Genuine Caution: Benzoyl Peroxide

Thiboutot and colleagues' research on clindamycin-benzoyl peroxide combination formulation provides relevant context for understanding benzoyl peroxide's documented oxidative interaction relevance, reasonably extended to combination with AHA/BHA given cumulative irritation potential on already-sensitized skin, supporting time-separated rather than simultaneous application.[4]

Myth, Not Genuine Caution: Niacinamide

Draelos and colleagues' specific research on niacinamide-containing facial moisturizer's barrier-improving and rosacea-relevant benefit directly counters the persistent, widely circulated but unsubstantiated myth that niacinamide is chemically incompatible with AHA/BHA — contemporary formulation-chemistry evidence does not support a genuine, clinically significant incompatibility at typical cosmetic formulation pH ranges, representing an outdated concern rather than a genuine caution.[5]

Myth, Not Genuine Caution: Panthenol

Proksch, de Bony, Trapp, and Boudon's 70th-anniversary review of topical dexpanthenol use reinforces that panthenol carries no documented chemical incompatibility with AHA/BHA acids — this represents another example of an ingredient sometimes inaccurately flagged as incompatible without genuine supporting evidence, illustrating the importance of the substance-specific evaluation principle applied consistently throughout this literature.[7]

Myth, Not Genuine Caution: Panthenol | CIRÈLL
Myth, Not Genuine Caution: Panthenol

Conclusion

Genuine AHA/BHA incompatibilities rest on documented mechanisms — cumulative irritation with retinoids and benzoyl peroxide, and pH-based formulation conflict with low-pH vitamin C — while persistent myths about niacinamide or panthenol incompatibility do not hold up against contemporary formulation-chemistry evidence, supporting mechanism-specific rather than blanket avoidance strategy. For guidance on safely combining AHA/BHA with other actives, our pharmacist, Mine Ekber, is available for direct consultation via WhatsApp.

Frequently Asked Questions

Which ingredients genuinely should not be combined with AHA/BHA?

Retinoids and benzoyl peroxide carry genuine, documented cumulative irritation cautions, while low-pH vitamin C carries a genuine pH-based formulation conflict, supporting alternating or time-separated use for these specific combinations.

Is it true that niacinamide can't be used with AHA/BHA?

No — this is a persistent but unsubstantiated myth; contemporary formulation-chemistry evidence does not support a genuine, clinically significant incompatibility between niacinamide and AHA/BHA at typical cosmetic formulation pH ranges.

Does panthenol have any conflict with AHA/BHA acids?

No documented chemical incompatibility exists between panthenol and AHA/BHA acids, making this another example of an ingredient sometimes inaccurately flagged as incompatible without genuine supporting evidence.

References

  1. Tang S-C, Yang J-H. Dual Effects of Alpha-Hydroxy Acids on the Skin. Molecules. 2018;23(4):863.
  2. Zasada M, Budzisz E. Retinoids: active molecules influencing skin structure formation in cosmetic and dermatological treatments. Postepy Dermatol Alergol. 2019;36(4):392–397.
  3. Al-Niaimi F, Chiang NYZ. Topical Vitamin C and the Skin: Mechanisms of Action and Clinical Applications. J Clin Aesthet Dermatol. 2017;10(7):14–17.
  4. Thiboutot DM, et al. An aqueous gel fixed combination of clindamycin phosphate 1.2% and benzoyl peroxide 3.75% for the once-daily treatment of moderate-to-severe acne vulgaris. J Drugs Dermatol. 2014;13(9):1083–1089.
  5. Draelos ZD, et al. Niacinamide-containing facial moisturizer improves skin barrier and benefits subjects with rosacea. Cutis. 2005;76(2):135–141.
  6. Fluhr JW, Darlenski R. Skin surface pH: mechanism, measurement, importance. Curr Probl Dermatol. 2018;54:1–10.
  7. Proksch E, de Bony R, Trapp S, Boudon S. Topical use of dexpanthenol: a 70th anniversary article. J Dermatolog Treat. 2017;28(8):766–773.
  8. Leyden J, Stein-Gold L, Weiss J. Why Topical Retinoids Are Mainstay of Therapy for Acne. Dermatol Ther (Heidelb). 2017;7(3):293–304.

Further Reading

Back to blog

Leave a comment